Sleep Cycle AB (SE:SLEEP)
:SLEEP
Want to see SE:SLEEP full AI Analyst Report?
Top Page
Sleep Cycle AB
(SLEEP)
Select Model
Select Model
Rating:67Neutral
Price Target:
kr16.50
▼(-34.00% Downside)
Action:ReiteratedDate:05/01/26
The score is primarily supported by strong profitability and a low-debt balance sheet, with valuation also favorable (low P/E and solid yield). These positives are tempered by weakening cash flow/recent growth softness and a clearly bearish technical setup with the stock trading below all major moving averages.
Positive Factors
High profitability margins
Sustained high gross and operating margins indicate strong unit economics and pricing power in the app business. Durable margins support reinvestment into product, sustained profitability through cycles, and the ability to fund marketing or R&D without immediate outside capital.
Negative Factors
Revenue decline
Negative trailing revenue growth signals demand softness or slowing user monetization. Over months this erodes scale benefits in a software model, limits ARR expansion, and constrains the company's ability to leverage fixed costs to grow margins further.
Read all positive and negative factors
Positive Factors
Negative Factors
High profitability margins
Sustained high gross and operating margins indicate strong unit economics and pricing power in the app business. Durable margins support reinvestment into product, sustained profitability through cycles, and the ability to fund marketing or R&D without immediate outside capital.
Read all positive factors
Sleep Cycle AB (SLEEP) vs. iShares MSCI Sweden ETF (EWD)
Market Cap
kr311.06M
Dividend Yield7.64%
Average Volume (3M)46.23K
Price to Earnings (P/E)15.6
Beta (1Y)0.18
Revenue Growth-10.44%
EPS Growth-30.79%
CountrySE
Employees33
SectorTechnology
Sector Strength88
IndustrySoftware - Application
Share Statistics
EPS (TTM)0.27
Shares Outstanding20,277,563
10 Day Avg. Volume28,513
30 Day Avg. Volume46,232
Financial Highlights & Ratios
PEG Ratio-0.64
Price to Book (P/B)7.24
Price to Sales (P/S)2.10
P/FCF Ratio9.84
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)1.63
Revenue Forecast (FY)kr238.18M
Sleep Cycle AB Business Overview & Revenue Model
Company Description
Sleep Cycle AB (SLEEP) is a technology company specializing in sleep tracking and improvement solutions. The company operates primarily in the health and wellness sector, offering a mobile application that analyzes users' sleep patterns and provid...
How the Company Makes Money
Sleep Cycle primarily makes money by monetizing its Sleep Cycle mobile app through paid subscriptions. Users can download and use a free version with limited functionality, while advanced features are offered via recurring subscription plans (typi...
Sleep Cycle AB Financial Statement Overview
Summary
Income Statement
78
Positive
Balance Sheet
86
Very Positive
Cash Flow
70
Positive
| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 238.58M | 247.88M | 261.53M | 236.15M | 213.27M | 182.94M |
| Gross Profit | 89.58M | 121.36M | 201.87M | 128.55M | 156.65M | 141.62M |
| EBITDA | 63.40M | 73.62M | 88.45M | 64.05M | 46.27M | 12.37M |
| Net Income | 44.92M | 53.21M | 62.64M | 46.14M | 33.94M | 8.11M |
Balance Sheet | ||||||
| Total Assets | 207.07M | 200.15M | 236.49M | 230.54M | 301.37M | 227.76M |
| Cash, Cash Equivalents and Short-Term Investments | 115.27M | 120.85M | 144.82M | 133.47M | 232.86M | 165.51M |
| Total Debt | 6.60M | 7.38M | 11.74M | 15.92M | 4.20M | 2.49M |
| Total Liabilities | 129.73M | 128.31M | 157.04M | 169.55M | 140.54M | 118.86M |
| Stockholders Equity | 77.34M | 71.83M | 79.46M | 61.00M | 160.83M | 108.90M |
Cash Flow | ||||||
| Free Cash Flow | 33.20M | 52.88M | 59.73M | 51.00M | 53.76M | 14.15M |
| Operating Cash Flow | 43.40M | 52.93M | 63.66M | 52.72M | 61.53M | 20.09M |
| Investing Cash Flow | -21.33M | -13.15M | -3.92M | -6.81M | -7.77M | -5.93M |
| Financing Cash Flow | -63.90M | -64.19M | -48.36M | -145.30M | 14.01M | 98.22M |
Sleep Cycle AB Technical Analysis
Positive
25.00
Price Trends
16.19
Positive
19.83
Negative
23.32
Negative
Market Momentum
0.19
Negative
60.15
Neutral
69.20
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For SE:SLEEP, the sentiment is Positive. The current price of 25 is above the 20-day moving average (MA) of 16.75, above the 50-day MA of 16.19, and above the 200-day MA of 23.32, indicating a neutral trend. The MACD of 0.19 indicates Negative momentum. The RSI at 60.15 is Neutral, neither overbought nor oversold. The STOCH value of 69.20 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for SE:SLEEP.
Sleep Cycle AB Peers Comparison
UnderperformOutperform
Sector (61)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | kr457.88M | 18.38 | ― | 3.48% | 4.11% | 13.90% | |
67 Neutral | kr311.06M | 15.62 | 96.69% | 7.64% | -10.44% | -30.79% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
60 Neutral | kr61.12M | 24.78 | ― | ― | -0.60% | ― | |
55 Neutral | kr255.90M | -0.85 | ― | ― | -19.34% | -1.24% | |
49 Neutral | kr95.34M | -1.20 | -83.82% | ― | -9.82% | -582.07% | |
45 Neutral | kr35.50M | -22.88 | ― | ― | -28.58% | -1329.84% |
* Technology Sector Average
SE:SLEEP
Sleep Cycle AB
15.34
-14.74
-49.00%
SE:CHECK
Checkin.com Group AB
3.19
-4.57
-58.89%
SE:FLOWS
Flowscape Technology AB
3.12
-0.25
-7.42%
SE:GENI
Generic Sweden AB
37.25
-20.70
-35.72%
SE:MOBA
M.O.B.A. Network AB
1.57
-4.98
-76.11%
SE:BUSER
Bambuser AB
31.80
17.80
127.14%
Sleep Cycle AB Corporate Events
Sleep Cycle Posts Weaker Q1 as It Accelerates Shift Toward Sleep Health Platform
Apr 29, 2026
Sleep Cycle reported a weak first quarter, with net sales down 19% to SEK 52.6 million, EBITDA nearly halved and paying subscribers falling to 715,000, though revenue from its smaller B2B segment grew sharply and now accounts for 14.5% of sales. T...
Sleep Cycle to Present First-Quarter 2026 Results in Webcast
Apr 28, 2026
Sleep Cycle AB, a Nasdaq Stockholm–listed sleep technology specialist based in Gothenburg, develops an app that leverages patented sound analysis and billions of recorded sleep sessions to provide users with accurate monitoring and personali...
Sleep Cycle AGM Confirms Dividend, Re-Elects Board and Auditor
Apr 13, 2026
Sleep Cycle AB held its Annual General Meeting on 13 April 2026, where shareholders approved the 2025 income statements and balance sheets and resolved on a dividend of SEK 0.53 per share, with payment to be processed later in April. The meeting a...
Sleep Cycle extends Revolut partnership to 2027, deepening push into digital wellness
Apr 9, 2026
Sleep Cycle has renewed and extended its strategic partnership with global fintech player Revolut until June 2027, ensuring its AI-driven sleep optimization app remains part of Revolut’s exclusive offers for millions of eligible users worldw...
Sleep Cycle Sees Strong Early Demand for AI Sleep Apnea Risk Tool
Mar 31, 2026
Sleep Cycle is deepening its push into medical technology with an AI-powered sleep apnea risk detection tool, leveraging its established audio-based sleep analysis platform to deliver at-home assessments embedded in users’ normal sleep routi...
Sleep Cycle Unveils AI-Based Sleep Score to Power Coaching and Partnerships
Mar 24, 2026
Sleep Cycle has introduced an AI-powered Sleep Score within its app and technical platform, shifting from a traditional focus on sleep duration toward a model built on three pillars: Duration, Quality, and Routine. Drawing on recent research that ...
Sleep Cycle Calls 2026 AGM With In-Person and Postal Voting Options
Mar 9, 2026
Sleep Cycle AB has called its Annual General Meeting for 13 April 2026 in Gothenburg, Sweden, giving shareholders the option to participate either in person or through postal voting in line with its Articles of Association. Shareholders must be re...
Sleep Cycle Bolsters Medtech Push With Strategic Senior Hires
Feb 25, 2026
Sleep Cycle is evolving from a consumer sleep app provider into a diversified medtech platform, combining global consumer reach, proprietary AI, and medical validation to address sleep health at scale. Listed on Nasdaq Stockholm and headquartered ...
Sleep Cycle teams with Carnegie Mellon to turn cough data into outbreak early-warning signals
Feb 18, 2026
Sleep Cycle AB, a Gothenburg-headquartered AI sleep technology firm best known for its consumer sleep-tracking app and data-driven wellness tools, continues to expand beyond its core digital sleep services and corporate partnership program. By com...
Sleep Cycle leans on health-tech tie-ups as revenue softens
Feb 4, 2026
Sleep Cycle’s 2025 year-end report shows a tightened focus on SDK licensing and health-tech partnerships—highlighted by collaborations with Ultrahuman, a global IoT player, and a CRO-backed AI sleep apnea validation study—even as...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.